GT
NTUS

Glenmede Trust’s Natus Medical Inc NTUS Stock Holding History

Glenmede Trust’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-460
Closed -$7K – 2467
2020
Q3 		$7K Hold
460
– – ﹤0.01% 2020
2020
Q2 		$10K Buy
460
+34
+8% +$778 ﹤0.01% 1892
2020
Q1 		$14K Hold
426
– – ﹤0.01% 2275
2019
Q4 		$14K Buy
426
+100
+31% +$3.21K ﹤0.01% 2275
2019
Q3 		$10 Buy
326
+45
+16% +$1.31K ﹤0.01% 2368
2019
Q2 		$7 Hold
281
– – ﹤0.01% 2524
2019
Q1 		$7 Hold
281
– – ﹤0.01% 2511
2018
Q4 		$9 Buy
+281
New +$9.14K ﹤0.01% 2333
2018
Q3 		– Sell
-3,058
Closed -$106K – 1902
2018
Q2 		$106K Buy
3,058
+2,901
+1,848% +$102K ﹤0.01% 1246
2018
Q1 		$5K Hold
157
– – ﹤0.01% 2417
2017
Q4 		$5K Sell
157
-8,387
-98% -$335K ﹤0.01% 2417
2017
Q3 		$319K Sell
8,544
-8,456
-50% -$298K ﹤0.01% 1055
2017
Q2 		$666K Hold
17,000
– – ﹤0.01% 858
2017
Q1 		$666K Buy
17,000
+223
+1% +$8.37K ﹤0.01% 858
2016
Q4 		$583K Hold
16,777
– – ﹤0.01% 900
2016
Q3 		$658K Hold
16,777
– – ﹤0.01% 843
2016
Q2 		$633K Sell
16,777
-242
-1% -$8.11K ﹤0.01% 849
2016
Q1 		$652K Sell
17,019
-157
-0.9% -$5.85K ﹤0.01% 840
2015
Q4 		$823K Sell
17,176
-162
-0.9% -$7.5K 0.01% 793
2015
Q3 		$683K Buy
17,338
+103
+0.6% +$4.38K 0.01% 808
2015
Q2 		$732K Buy
17,235
+116
+0.7% +$4.62K 0.01% 817
2015
Q1 		$675K Hold
17,119
– – ﹤0.01% 857
2014
Q4 		$615K Sell
17,119
-3,430
-17% -$115K ﹤0.01% 846
2014
Q3 		$605K Sell
20,549
-5,624
-21% -$155K 0.01% 817
2014
Q2 		$657K Buy
26,173
+106
+0.4% +$2.62K 0.01% 800
2014
Q1 		$672K Sell
26,067
-22
-0.1% -$554 0.01% 792
2013
Q4 		$586K Sell
26,089
-204
-0.8% -$3.94K 0.01% 803
2013
Q3 		$372K Hold
26,293
– – ﹤0.01% 920
2013
Q2 		$357K Buy
+26,293
New +$358K ﹤0.01% 883

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Glenmede Trust's NTUS Position: Q4 2020 in Review

Glenmede Trust sold out of Natus Medical Inc (NTUS) in Q4 2020, closing a stake of 460 shares — an estimated $7K sold.

Glenmede Trust first reported a position in NTUS in Q2 2013 and held it in 29 quarters. The position peaked at $823K in Q4 2015. 163 funds tracked by Wall St. Rank hold NTUS as of Q4 2020.

  • Glenmede Trust reported no remaining Natus Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 460 Natus Medical Inc shares in Q4 2020, an estimated $7K.
  • Glenmede Trust first reported a position in Natus Medical Inc in Q2 2013 and held it in 29 quarters.
  • Glenmede Trust's Natus Medical Inc position peaked at $823K in Q4 2015.
  • 163 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.